Skip to content
Peptide research

Glutathione

Also known as GSH
Category
Longevity & Anti-Aging
Administration routes
InjectableOral
Regulatory status
Not FDA-approved

What it is

The body's master antioxidant, a tripeptide that neutralizes free radicals, aids liver detox, and recycles vitamins C and E. Evidence is strongest for reduced oxidative stress and better blood sugar in elderly diabetics; broader immune and neuroprotective claims rest on thin data. IV use carries real risk, including liver dysfunction and severe reactions from misused skin-lightening use. Not FDA-approved; sold mainly as an unregulated supplement.

Read Full record

Studied uses & evidence

Studied uses(8)

  • Master antioxidant defense — neutralizes reactive oxygen/nitrogen species (ROS/RNS), reduces hydrogen peroxide, organic hydroperoxides, and lipid peroxides

    Medium

    Human trials raise glutathione levels reliably; effects on oxidative damage markers are mixed.

  • Xenobiotic and toxin detoxification — conjugates electrophilic compounds via glutathione S-transferases (GSTs) for excretion; shown to reduce blood mercury by 39% in 30 days

    Speculative

    The 39% mercury reduction figure comes from one small uncontrolled study, not a controlled trial.

  • Immune system enhancement — NK cell cytotoxicity increased up to 400%, lymphocyte proliferation increased up to 60%

    Medium

    One RCT found roughly doubled NK activity. A separate uncontrolled 12-person pilot reported up to 400% higher NK cytotoxicity and 60% higher lymphocyte proliferation; these were laboratory immune markers.

Evidence limits

Evidence Level
Moderate-to-Strong

Strong biochemical evidence for antioxidant, detoxification, and immune roles. Multiple RCTs demonstrate that oral and liposomal glutathione supplementation significantly raises body stores of GSH across blood compartments. Clinical efficacy shown for immune enhancement (NK cell cytotoxicity), insulin sensitivity improvement, and oxidative stress reduction. However, some trials show no change in systemic oxidative stress biomarkers in healthy adults, suggesting benefits are most pronounced in GSH-depleted or metabolically stressed populations. Long-term safety data beyond 6 months remains limited.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Asthma (inhaled form)

    Moderate

    Inhaled glutathione can trigger bronchospasm in asthmatic patients.

  • Organ transplant recipients

    Moderate

    Antioxidant/immune modulation may interfere with immunosuppressive drug efficacy.

Risk summary(10)

Risks = level of concern: High · Moderate · Low · Theoretical

  • GI side effects: Mild gastrointestinal discomfort, bloating, cramping, and loose stools, especially at higher oral doses

    Low
  • Allergic reactions: Rare but possible; severe anaphylaxis reported with IV administration (one case in skin lightening review)

    Moderate
  • IV-specific risks: 32% adverse event rate in one study including liver dysfunction; injection site reactions; risk of air embolism or sepsis with improper administration

    High
  • Zinc depletion: Long-term or high-dose supplementation may reduce zinc levels through mineral chelation/interaction

    Theoretical
  • Potential thyroid effects: Case reports and preliminary studies suggest possible thyroid dysfunction with chronic high-dose use, particularly IV formulations

    Low
  • Chemotherapy interference: May reduce effectiveness of alkylating agents and platinum-based chemotherapy (cisplatin) by enhancing drug conjugation and efflux

    Low
  • Asthma exacerbation: Inhaled glutathione may worsen asthma symptoms in susceptible individuals

    High
  • Pregnancy/lactation: Insufficient safety data; not recommended during pregnancy or breastfeeding without medical supervision

    Moderate
  • Skin lightening misuse: Unregulated IV use for skin lightening has led to severe adverse events including Stevens-Johnson syndrome and toxic epidermal necrolysis

    High
  • Rebound oxidative stress: Abrupt cessation after prolonged high-dose supplementation may temporarily reduce endogenous GSH production

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.